期刊文献+

周剂量紫杉醇联合5-氟尿嘧啶/醛氢叶酸二线治疗晚期胃癌疗效观察 被引量:2

Weekly dose of taxol combined 5-Fu+LV in treat mene of advanced stomach cancer
下载PDF
导出
摘要 目的观察周剂量紫杉醇联合5-氟尿嘧啶/醛氢叶酸二线治疗晚期胃癌的近期疗效,毒副作用及生活质量的改善情况.方法25例晚期胃癌病人接受紫杉醇(PTX)60mg/m2静点3小时,第1,8,15天;醛氢叶酸(LV)200mg/次静点2小时,第1~5天;5-氟尿嘧啶(5-Fu)350mg/m2静点4~6小时,第1~5天。3周为1周期,2周期为1疗程。所有病人至少接受2周期以上。客观疗效(CR+PR)与毒副作用按WHO标准进行评价,生活质量按临床受益疗效评价。结果25例均可评价疗效,完全缓解(CR)0例,部分缓解(PR)12例,总有效率48%,临床受益反应有效率76%。中位TTP为5.8月。主要毒副反应为骨髓抑制,消化道反应及神经毒性均为I^II级,可以耐受。结论周剂量紫杉醇联合5-氟尿嘧啶+醛氢叶酸二线治疗晚期胃癌近期疗效明显。病人生活质量明显改善,耐受性好。 Objective : To observe the short term curative effect , toxicity and quality of life with weekly dose of taxol combined 5 - FU + LV treat advanced stomach cancer. Motheds: Twenty five cases with advanced gastric cancer were observed. PTX 60mg/m^2 iv for 3hr ,d1. LV 200mg iv for 2hr, d1 - 5.5 -FU 350mg/m^2 iv for 4 - 6hr, d1 - 5 and repeated every 21 days. To evaluate CR + PR and toxicity refer to WHO standard. Quality of life refer to clinical benefited response. Results: Total effective rate was 48%. Median TIP was 5.8 months. Myelosuppresion ,toxicity of digestive tract and nerve all were Ⅰ - Ⅱ and tolerable . Clinical benefit effect rate was 76%. Conclusion: Weekly dose of taxol combined 5 - FU + LV treating advanced stomach cancer, the short term curative effect was 48%. Quality of life is improved obviously.
出处 《现代肿瘤医学》 CAS 2006年第7期855-857,共3页 Journal of Modern Oncology
关键词 晚期胃癌 紫杉醇 氟尿嘧啶 醛氢叶酸 联合化疗 advanced gastric cancer taxol 5 - fluorouracil leucovoron chemotherapy
  • 相关文献

参考文献7

  • 1Burris Ha,Moore M J,Anderson J,et al,Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer; a randomized trial[J].J Clin Oncol,1997,15:2403 ~ 2413.
  • 2Glimelius B,Ekstrom K,Hoffman K,et al.Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer[J].Ann Oncol,1997,8:163.
  • 3Wike H,Preusser P,Fink U,et al.New developments in the treatment of gastric carcinoma[J].semin oncol,1990,17 (Suppl2):61~70.
  • 4Lopez R.Weekly double biochemical modulation of cisplatin,Leucovorin and 5-fluorouracil in advanced gastric cancer[J].Proc Asco,1997,16:1053.
  • 5Louvet C,Andre T,Tigaud JM,et al.Phase Ⅱ study of Oxaliplatin,Fluorouracil,and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20 (23):4543 ~4548.
  • 6Klauber N,Parangis,Flynn E,et al.Inhibition of angiogenesis and breast cancer in mice by the microtubule inhibition 2-methoxyestradiol paclitaxel[J].Cancer Res,1997,57 (1):81.
  • 7沈波,史美祺,潘良熹.周剂量紫杉醇联合LD-FP方案治疗晚期消化道肿瘤临床观察[J].中国癌症杂志,2001,11(6):565-565. 被引量:15

二级参考文献1

共引文献14

同被引文献13

  • 1王文武,欧阳学农,彭永海.晚期胃癌不同化学治疗方案的疗效比较[J].中国综合临床,2005,21(12):1121-1123. 被引量:2
  • 2孙燕.临床肿瘤内科手册.4版.北京:人民卫生出版社,2003.571.
  • 3Ugo D, Persiani R, Pende V,et al. Neoadjuvant chemotherapy in gastric carcinoma. Ann hal Chir,2001,72( 1 ) :47.
  • 4Ppllock RE.临床肿瘤学手册[M].长春:吉林科学技术出版社,2000.477~478.
  • 5Raymond E,Chaney SG,Taamma A,et al.Oxaliplantin:a review of preclinical and clinical studies[J].Ann Oncol,1998,9(10):1053~1077.
  • 6Giacchetti S,Perpoint B,Zidani R,et al.Phase Ⅲ multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracio leucovorin and first-line treatment of metastatic colorectal cancer[J].J Clin Oncol,2000,18(1):136~147.
  • 7Klaube RN,parangi S,Flynn E,et al.Inhibition of angiogenesis and brest cancer in mile by the microtubule inhibitiors2-Mehtoxyestra-dial and paclitaxel[J].Cancer Res,1997,57(1):81.
  • 8Chang YF,Li LL,Wu CW,et al.paclitaxel-induced apoptosis in human gastric carcinoma cell lines[J].Cancer,1996,77(1):14~18.
  • 9唐友明.FOLFOX4改良方案治疗老年晚期直肠癌的疗效观察[J].中国基层医药,2008,15(8):1366-1366. 被引量:3
  • 10杨锡贵,宋恕平,陈阵,周登光,牛作兴,郭珺,盛立军,刘波.含草酸铂方案治疗晚期胃癌近期疗效分析——附18例报告[J].肿瘤防治杂志,2002,9(1):76-78. 被引量:32

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部